---
title: "Kimia Biosciences Ltd (530313) — Share Price, Financials & Analysis"
symbol: "530313"
company: "Kimia Biosciences Ltd"
canonical: "https://tapetide.com/stocks/530313"
isin: "INE285U01025"
nse_symbol: "KIMIABIOSCIENCESLTD"
bse_code: "530313"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 135.39
generated_at: "2026-09-13T19:59:51.187Z"
---

# Kimia Biosciences Ltd (530313)

Canonical page: https://tapetide.com/stocks/530313

## Company

- **NSE Symbol:** KIMIABIOSCIENCESLTD
- **BSE Code:** 530313
- **ISIN:** INE285U01025
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **CEO:** Mr. Sameer Goel
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** kimiabiosciences.com

## About

Incorporated in 1993, Kimia Biosciences 
Ltd is in the business of manufacturing 
and sale pharmaceutical products[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:49:46.255044Z.

- **Market Cap:** ₹135.39 Cr
- **Classification:** Microcap
- **P/E (reported):** 19.4
- **EPS (TTM):** ₹1.53
- **EPS (reported):** ₹0
- **Book Value:** ₹3.75
- **Price to Book:** 7.88
- **Dividend Yield:** 0%
- **ROE:** 96.45%
- **ROCE:** 61.9%
- **Debt to Equity:** 1.94
- **Revenue (yearly):** ₹114.88 Cr
- **Net Income:** ₹8.46 Cr
- **EBITDA:** ₹14.26 Cr
- **52-Week High:** ₹43.28
- **52-Week Low:** ₹23.2
- **RSI (14):** 52.03

## Tapetide Score

- **Score:** 45 / 100
- **Score date:** 2026-09-04
- **Archetype:** Expensive and Under Pressure
- **What it means:** The multiple is demanding and the trend has turned against it, without the financial strength that would justify paying up. What matters is whether the de-rating stops at the multiple or starts showing up in the numbers.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Falling
- **Percentile:** 28.3 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 27.47 | 9% |
| growth | 27.84 | 9% |
| momentum | 39.76 | 12% |
| ownership | 50 | 24% |
| quality | 57.29 | 22% |
| valuation | 48.1 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has a good return on equity (ROE) track record: 3 Years ROE 53.6%

### Weaknesses

- Stock is trading at 7.37 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -2.84% over past five years.
- Tax rate seems low

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 46.66% | 414.77% | 256.95% |
| ebitda margin growth | -35.14% | -31.77% | — | 887.1% |
| net income growth | 0% | -11.87% | 43% | 8% |
| revenue growth | -26.24% | -4.43% | -4% | -3% |
| roce | — | -985.55% | -441.42% | 9.98% |
| roe | — | -106.01% | -559.53% | 248.32% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 24.2 | 26.14 | 30.3 | 22.4 | 28.18 | 30.1 | 38.24 | 23.58 | 34 | 30.1 | 27.2 | 20.72 |
| Expenses | 26.16 | 27.19 | 26.14 | 18.69 | 24.81 | 25.1 | 30.06 | 21.05 | 31.48 | 23.54 | 24.54 | 18.37 |
| Operating Profit | -1.96 | -1.05 | 4.16 | 3.71 | 3.37 | 5 | 8.18 | 2.53 | 2.52 | 6.56 | 2.66 | 2.35 |
| OPM % | -8.1 | -4.02 | 13.73 | 16.56 | 11.96 | 16.61 | 21.39 | 10.73 | 7.41 | 21.79 | 9.78 | 11.34 |
| Other Income | 0.64 | 0.58 | 0.3 | 0.08 | 0.37 | 0.42 | 0.44 | 0.85 | -0.33 | 0.1 | 1.01 | 0.08 |
| Interest | 1.12 | 1.31 | 1.34 | 1.11 | 1.04 | 1.01 | 1.4 | 1.75 | 0.27 | 0.75 | 0.75 | 0.83 |
| Depreciation | 0.82 | 0.82 | 0.82 | 0.9 | 0.79 | 0.82 | 0.88 | 0.94 | 0.97 | 0.85 | 1.16 | 1.11 |
| Profit before tax | -3.26 | -2.6 | 2.3 | 1.78 | 1.91 | 3.59 | 6.34 | 0.69 | 0.95 | 5.06 | 1.76 | 0.49 |
| Tax % | -25.15 | -25 | 22.17 | 19.66 | 15.71 | -27.3 | 68.61 | 13.04 | -7.37 | -7.71 | 78.98 | 26.53 |
| Net Profit | -2.44 | -1.95 | 1.8 | 1.44 | 1.61 | 4.57 | 1.99 | 0.6 | 1.02 | 5.44 | 0.37 | 0.36 |
| EPS in Rs | -0.52 | -0.41 | 0.38 | 0.3 | 0.34 | 0.97 | 0.42 | 0.13 | 0.22 | 1.15 | 0.08 | 0.08 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 76 | 94 | 106 | 133 | 125 | 129 | 105 | 119 | 115 | 112 |
| Expenses | 74 | 88 | 102 | 124 | 124 | 133 | 105 | 99 | 101 | 98 |
| Operating Profit | 2 | 6 | 4 | 8 | 1 | -5 | 0 | 20 | 14 | 14 |
| OPM % | 3.2 | 6 | 4.2 | 6 | 0.5 | -3.9 | -0.5 | 17 | 12 | 13 |
| Other Income | 1 | 1 | 1 | 2 | 1 | 0 | 2 | 1 | 2 | 1 |
| Interest | 1 | 2 | 3 | 3 | 4 | 4 | 5 | 5 | 4 | 3 |
| Depreciation | 1 | 1 | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 4 |
| Profit before tax | 2 | 4 | 1 | 6 | -5 | -12 | -7 | 14 | 8 | 8 |
| Tax % | -4 | -1 | -13 | 8 | -26 | -25 | -26 | 29 | 12 | — |
| Net Profit | 2 | 4 | 1 | 5 | -4 | -9 | -5 | 10 | 7 | 7 |
| EPS in Rs | 2.26 | 2.64 | 0.3 | 1.08 | -0.78 | -1.98 | -1.12 | 2.03 | 1.57 | 1.53 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 7 | 1 | 1 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | -12 | 0 | 4 | 9 | 14 | 10 | 1 | -4 | 5 | 13 |
| Borrowings | 14 | 34 | 31 | 34 | 45 | 41 | 53 | 44 | 33 | 35 |
| Other Liabilities | 3 | 22 | 29 | 38 | 43 | 54 | 63 | 56 | 68 | 51 |
| Total Liabilities | 12 | 58 | 65 | 86 | 107 | 109 | 121 | 100 | 111 | 103 |
| Fixed Assets | 7 | 13 | 16 | 18 | 28 | 35 | 34 | 32 | 33 | 37 |
| CWIP | 3 | 2 | 2 | 6 | 6 | 0 | 1 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 2 | 43 | 48 | 62 | 72 | 74 | 87 | 68 | 78 | 66 |
| Total Assets | 12 | 58 | 65 | 86 | 107 | 109 | 121 | 100 | 111 | 103 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -1 | -7 | -3 | 0 | 6 | 8 | -7 | 15 | 21 | 11 |
| Cash from Investing Activity | -6 | -2 | -2 | -9 | -14 | -1 | -3 | -1 | -5 | -8 |
| Cash from Financing Activity | 7 | 10 | 4 | 8 | 8 | -8 | 10 | -13 | -17 | -3 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | -7 | -10 | -5 | -9 | -8 | 6 | -10 | 13 | 17 | 3 |
| CFO/OP | 85 | -287 | -45 | 5 | 71 | 1281 | 136 | -3021 | 105 | 76 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 20 | 141 | 113 | 128 | 115 | 88 | 87 | 96 | 113 | 93 |
| Inventory Days | 615 | 59 | 83 | 92 | 89 | 146 | 183 | 149 | 178 | 137 |
| Days Payable | 511 | 120 | 91 | 121 | 116 | 159 | 177 | 194 | 260 | 220 |
| Cash Conversion Cycle | 124 | 80 | 105 | 100 | 88 | 76 | 93 | 51 | 31 | 10 |
| Working Capital Days | -1358 | 48 | 62 | 73 | 53 | 31 | 16 | -30 | -22 | 5 |
| ROCE % | -10 | 10 | 16 | 9 | 16 | -2 | -12 | -4 | 42 | 25 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 23.04% | 23.04% | 23.05% | 23.05% | 23.03% | 22.94% | 23.04% | 23.04% | 22.93% | 22.92% | 22.88% | 22.88% |
| Others | 1.64% | 1.64% | 1.63% | 1.63% | 1.65% | 1.74% | 1.64% | 1.64% | 1.75% | 1.75% | 1.8% | 1.8% |
| No. of Shareholders | 12118 | 12063 | 12110 | 12023 | 12179 | 12231 | 12278 | 12200 | 12616 | 12751 | 12775 | 12775 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 1 / 7 / 11

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 29.03 | Sell |
| EMA (10) | 28.8 | Sell |
| SMA (20) | 28.51 | Sell |
| EMA (20) | 28.91 | Sell |
| SMA (50) | 30.15 | Sell |
| EMA (50) | 29.94 | Sell |
| SMA (100) | 32.38 | Sell |
| EMA (100) | 31.15 | Sell |
| SMA (200) | 31.93 | Sell |
| EMA (200) | 33.35 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 40.95 | Neutral |
| MACD (12,26,9) | -0.28 | Buy |
| Stochastic (14,3,3) | 66.11 | Neutral |
| ADX (14) | 19.14 | Neutral |
| Williams %R (14) | -56.16 | Neutral |
| ATR (14) | 1.52 | High Volatility |
| ROC (12) | -1.04 | Sell |
| Stoch RSI (14) | 25.49 | Neutral |
| UO (7,14,28) | 47.03 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-07 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c93c770-7a9c-4c43-a156-86550978204e.pdf) |
| 2026-09-04 | [Intimation Of 33Rd Annual General Meeting Of The Company Proposed To Be Held On September 28 2026 At 3:00 P.M. Through Video Conferencing/Other Audio Visual Means.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ef204d4-2371-4a7f-9bfe-547557738760.pdf) |
| 2026-09-04 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3370e158-3a49-44cb-ac92-7423f287ed68.pdf) |
| 2026-09-04 | [Intimation Of Cut-Off Date/ Record Date E-Voting And AGM Date For The 33Rd Annual General Meeting.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e97bf887-3a4e-413f-8ef0-0d34e6d00f26.pdf) |
| 2026-09-04 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7cf93dd-3eb1-47ce-8b17-b5225fdff7cb.pdf) |
| 2026-09-03 | [Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On September 03 2026 Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40a38c54-fbc4-4fb1-9589-ba2c48e8d1bb.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48a811d3-95ae-43a6-9b48-439e43c3ab89.pdf) |
| 2026-08-10 | [Board Meeting Outcome for Outcome Of Board Meeting Held On August 10 2026 (Monday)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cee03c5d-e44d-4440-a162-79ede8603f8f.pdf) |
| 2026-08-03 | [Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations 2015 -Intimation Of Meeting Of Board Of Directors.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31c90888-c5d5-4818-bf9c-9d237a93b07d.pdf) |
| 2026-08-01 | [Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On August 1 2026 Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=329e0efb-bc3a-4f75-a183-24ffb8a04d92.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-10 | [Unaudited Financial Results For The First Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5735340e-e640-42ed-a2bb-d963097ed046.pdf) |
| 2026-05-29 | [Outcome Of The Board Meeting Held On 29 May 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7a46936-c474-48c3-bc1c-5628f72d910c.pdf) |
| 2026-02-14 | [Financials Results For The Quarter And Nine Months Ended 31 December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=193dc3e0-989f-43c1-8fa4-ec8411b70250.pdf) |
| 2025-11-14 | [Results Financials For The Quarter And Half Year Ended On 30-09-2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51dc16b7-5660-4c84-aae6-f5c68270c99e.pdf) |
| 2025-08-14 | [Financial Results For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3986c4de-061b-4f1b-941b-f415b905a165.pdf) |
| 2025-05-28 | [Financial Results Ended On 31 March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef3a7b1c-3f4e-4c42-b489-66de9e6e13af.pdf) |
| 2025-02-13 | [Integrated Filing (Financial) For The Quarter And Nine Months Ended 31St December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4ceb8be-6cce-453d-8eb4-754b540eaa29.pdf) |
| 2024-11-14 | [Results_Financial Statement Ending On 30 September 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3eaefa04-a30e-4dbf-999c-e7d5520277b0.pdf) |
| 2024-11-14 | [Results For The Half Financial Year September 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52e091be-64b5-497b-a71a-6e7bd1667b72.pdf) |
| 2024-08-20 | [Unaudited Quarterly Financial Results For The Quarter Ended On 30Th June,2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75b5ec6a-e172-41f4-b412-cbbcbeacb2ae.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7h - Board appoints Mr. Mani Jain as CFO and KMP effective April 27, 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 7h - Board appoints Mr. Mani Jain as CFO and KMP effective April 27, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/318b0e32-523c-49ea-8a2f-aa48e5ed191e.pdf) |
| 4 Apr - On 4 Apr 2026, Kimia appointed two independent directors, named a new CS, and noted one director exit. | [Announcement under Regulation 30 (LODR)-Change in Management 4 Apr - On 4 Apr 2026, Kimia appointed two independent directors, named a new CS, and noted one director exit.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/408810e8-3b8d-4611-96c8-0c397bc06b04.pdf) |
| 30 Jan - Board meeting Feb 12, 2026 to approve Q3/9M Dec 31,2025 unaudited results; trading window reopens after 48 hours. | [Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025. 30 Jan - Board meeting Feb 12, 2026 to approve Q3/9M Dec 31,2025 unaudited results; trading window reopens after 48 hours.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/61557ae9-25ae-4902-a119-a79d68a80a43.pdf) |
| 3 Apr - Pallavi Garg resigned as Company Secretary and Compliance Officer effective close of business April 3, 2026. | [Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer 3 Apr - Pallavi Garg resigned as Company Secretary and Compliance Officer effective close of business April 3, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/93d764f8-6844-48df-9103-f3da81ba9676.pdf) |
| 2d - Approved Q3/9M Dec31,2025 results; re-appointment of MD Sameer Goel w.e.f.14 Feb 2026; postal ballot for approvals. | [Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI(Listing Obligations And Disclosures Requirement) Regulation 2015 2d - Approved Q3/9M Dec31,2025 results; re-appointment of MD Sameer Goel w.e.f.14 Feb 2026; postal ballot for approvals.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/83a8e194-8b6d-4848-a5ce-9780d8a77535.pdf) |
| 27 Apr - Board appoints Mr. Mani Jain as CFO and KMP effective April 27, 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 27 Apr - Board appoints Mr. Mani Jain as CFO and KMP effective April 27, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/318b0e32-523c-49ea-8a2f-aa48e5ed191e.pdf) |
| 25 Mar - Trading window closed from 01-Apr-2026 until 48 hours after audited FY2026 results declaration. | [Closure of Trading Window 25 Mar - Trading window closed from 01-Apr-2026 until 48 hours after audited FY2026 results declaration.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bd017c2f-1e23-4e09-969f-691fbd381eee.pdf) |
| 20 Jan - GKB Ophthalmics: MSKA & Associates converted to MSKA & Associates LLP; will continue as statutory auditors (Jan 20, 2026). | [Intimation On Conversion Of Statutory Auditor''s Firm Into LLP- " MSKA & Associates" To MSKA & Associates LLP" Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015. 20 Jan - GKB Ophthalmics: MSKA & Associates converted to MSKA & Associates LLP; will continue as statutory auditors (Jan 20, 2026).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2e417fdf-8cb9-4934-a6b7-a7de18064c86.pdf) |
| 19 Feb - Executive Director Kaku Vijaya Shekhar Reddy resigned effective Feb 18, 2026; accepted Feb 19, 2026. | [Announcement under Regulation 30 (LODR)-Resignation of Director 19 Feb - Executive Director Kaku Vijaya Shekhar Reddy resigned effective Feb 18, 2026; accepted Feb 19, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1d2a3bbc-ceaf-4d57-ba5c-f788cf66f0e0.pdf) |
| 18 Apr - Board noted Richa Gupta’s exit, appointed Amulya Kumar Nayak, and modified Sameer Goel’s MD terms. | [Announcement under Regulation 30 (LODR)-Change in Management 18 Apr - Board noted Richa Gupta’s exit, appointed Amulya Kumar Nayak, and modified Sameer Goel’s MD terms.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ead72d68-6751-4d8b-ad92-b114b4a3a259.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b022cf14-3928-4db6-8107-e5e71667b3d1.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8780c26b-5db7-4b37-bcf1-ebcb8eec601f.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/db69f6df-ef36-4463-bdde-2e0a428ad497.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2f62611a-335f-40b5-bcb1-a310ca27712c.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8c43455f-e567-4f74-ad8e-ded4132a6410.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f87287fc-55cc-4e70-b8bb-a39cc8304d80.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/533212/76338533212.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/530313/76441530313.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/533212/70793533212.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/530313/70581530313.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:59:51.187Z.